AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: WHITEHEAD VM VUCHICH MJ COOLEY L LAUER SJ MAHONEY DH SHUSTER JJ PAYMENT C BERNSTEIN ML AKABUTU JJ BOWEN T KAMEN BA WATSON MS LOOK AT PULLEN DJ CAMITTA B
Citation: Vm. Whitehead et al., TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Clinical cancer research, 4(1), 1998, pp. 183-188
TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: WHITEHEAD VM VUCHICH MJ COOLEY L LAUER SJ MAHONEY DH SHUSTER JJ PAYMENT C BERNSTEIN ML AKABUTU JJ BOWEN T KAMEN BA WATSON MS LOOK AT PULLEN DJ CAMITTA B
Citation: Vm. Whitehead et al., TRANSLOCATIONS INVOLVING CHROMOSOME 12P11-13, METHOTREXATE METABOLISM, AND OUTCOME IN CHILDHOOD B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Clinical cancer research, 4(1), 1998, pp. 183-188
ADOPTIVE IMMUNOTHERAPY FOR LEUKEMIA - DONOR LYMPHOCYTES TRANSDUCED WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE FOR REMISSION INDUCTION
Authors: LINK CJ BURT RK TRAYNOR AE DROBYSKI WR SEREGINA T LEVY JP GORDON L ROSEN ST BURNS WH CAMITTA B CASPER J HOROWITZ M JUCKETT M LAWTON C MARGOLIS D PIETRYGA D ROWLINGS P TAYLOR C FURTADO M STEFKA J GUPTABURT S KAISER H VESOLE DH
Citation: Cj. Link et al., ADOPTIVE IMMUNOTHERAPY FOR LEUKEMIA - DONOR LYMPHOCYTES TRANSDUCED WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE FOR REMISSION INDUCTION, Human gene therapy, 9(1), 1998, pp. 115-134
SURFACE-ANTIGEN PHENOTYPE CAN PREDICT TEL-AML1 REARRANGEMENT IN CHILDHOOD B-PRECURSOR ALL - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BOROWITZ MJ RUBNITZ J NASH M PULLEN DJ CAMITTA B
Citation: Mj. Borowitz et al., SURFACE-ANTIGEN PHENOTYPE CAN PREDICT TEL-AML1 REARRANGEMENT IN CHILDHOOD B-PRECURSOR ALL - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Leukemia, 12(11), 1998, pp. 1764-1770
PROGNOSTIC-SIGNIFICANCE OF SEX IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: SHUSTER JJ WACKER P PULLEN J HUMBERT J LAND VJ MAHONEY DH LAUER S LOOK AT BOROWITZ MJ CARROLL AJ CAMITTA B
Citation: Jj. Shuster et al., PROGNOSTIC-SIGNIFICANCE OF SEX IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(8), 1998, pp. 2854-2863
ACUTE NEUROTOXICITY IN CHILDREN WITH B-PRECURSOR ACUTE LYMPHOID LEUKEMIA - AN ASSOCIATION WITH INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND INTRATHECAL TRIPLE THERAPY - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: MAHONEY DH SHUSTER JJ NITSCHKE R LAUER SJ STEUBER CP WINICK N CAMITTA B
Citation: Dh. Mahoney et al., ACUTE NEUROTOXICITY IN CHILDREN WITH B-PRECURSOR ACUTE LYMPHOID LEUKEMIA - AN ASSOCIATION WITH INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND INTRATHECAL TRIPLE THERAPY - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(5), 1998, pp. 1712-1722
INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE IS SUPERIOR TO REPETITIVE LOW-DOSE ORAL METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE FOR CHILDREN WITH LOWER-RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PHASE-III TRIAL
Authors: MAHONEY DH SHUSTER J NITSCHKE R LAUER SJ WINICK N STEUBER CP CAMITTA B
Citation: Dh. Mahoney et al., INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE IS SUPERIOR TO REPETITIVE LOW-DOSE ORAL METHOTREXATE WITH INTRAVENOUS MERCAPTOPURINE FOR CHILDREN WITH LOWER-RISK B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP PHASE-III TRIAL, Journal of clinical oncology, 16(1), 1998, pp. 246-254
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK NON-HODGKINS-LYMPHOMA - CLINICAL AND MOLECULAR FOLLOW-UP
Authors: JUCKETT M ROWLINGS P HESSNER M KEEVERTAYLOR C BURNS W CAMITTA B CASPER J DROBYSKI WR HANSON G HOROWITZ M LAWTON C MARGOLIS J PEITRYGA D VESOLE D
Citation: M. Juckett et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK NON-HODGKINS-LYMPHOMA - CLINICAL AND MOLECULAR FOLLOW-UP, Bone marrow transplantation, 21(9), 1998, pp. 893-899
ALTERNATIVE DONOR BMT FOR ACQUIRED APLASTIC-ANEMIA (SAA) 1986-1993
Authors: HOWS J CAMITTA B STONE J DEEG HJ HOROWITZ M
Citation: J. Hows et al., ALTERNATIVE DONOR BMT FOR ACQUIRED APLASTIC-ANEMIA (SAA) 1986-1993, Bone marrow transplantation, 21, 1998, pp. 171-171
ALTERNATIVE DONOR BMT FOR ACQUIRED APLASTIC-ANEMIA (SAA) 1986-1993
Authors: HOWS J CAMITTA B STONE J DEEG HJ HOROWITZ M
Citation: J. Hows et al., ALTERNATIVE DONOR BMT FOR ACQUIRED APLASTIC-ANEMIA (SAA) 1986-1993, British Journal of Haematology, 101, 1998, pp. 185-185
ETHNIC-DIFFERENCES IN THE SURVIVAL OF CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: POLLOCK BH DEBAUN MR CAMITTA B SHUSTER JJ PULLEN DJ MURPHY SB
Citation: Bh. Pollock et al., ETHNIC-DIFFERENCES IN THE SURVIVAL OF CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA, American journal of epidemiology, 147(11), 1998, pp. 184-184
ALTERNATIVE DONOR BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA
Authors: PASSWEG JR SCHREZENMEIER H CAMITTA B SOCIE G HOWS J ROWLINGS PA HOROWITZ MM
Citation: Jr. Passweg et al., ALTERNATIVE DONOR BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA, Experimental hematology, 25(8), 1997, pp. 180-180
EFFECT OF T-CELL SUBSET DOSE ON OUTCOME OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION
Authors: KAWANISHI Y PASSWEG J DROBYSKI WR ROWLINGS P COOKCRAIG A CASPER J PIETRYGA D GARBRECHT F CAMITTA B HOROWITZ M JUCKETT M MARGOLIS D FLOMENBERG N KEEVERTAYLOR CA
Citation: Y. Kawanishi et al., EFFECT OF T-CELL SUBSET DOSE ON OUTCOME OF T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(11), 1997, pp. 1069-1077
INCREASED FREQUENCY OF EXPRESSION OF ELEVATED DIHYDROFOLATE-REDUCTASEIN T-CELL VERSUS B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN
Authors: MATHERLY LH TAUB JW WONG SC SIMPSON PM EKIZIAN R BUCK S WILLIAMSON M AMYLON M PULLEN J CAMITTA B RAVINDRANATH Y
Citation: Lh. Matherly et al., INCREASED FREQUENCY OF EXPRESSION OF ELEVATED DIHYDROFOLATE-REDUCTASEIN T-CELL VERSUS B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN, Blood, 90(2), 1997, pp. 578-589
PREDICTABILITY OF THE TEL-AML1 REARRANGEMENT FROM SURFACE-ANTIGEN PHENOTYPE IN CHILDHOOD B-PRECURSOR ALL - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BOROWITZ MJ RUBNITZ J NASH M PULLEN DJ CAMITTA B
Citation: Mj. Borowitz et al., PREDICTABILITY OF THE TEL-AML1 REARRANGEMENT FROM SURFACE-ANTIGEN PHENOTYPE IN CHILDHOOD B-PRECURSOR ALL - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 90(10), 1997, pp. 3674-3674
UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDHOOD AML - AN UPDATE OF THE MILWAUKEE EXPERIENCE
Authors: MARGOLIS D PIETRYGA D CAMITTA B KEEVERTAYLOR C LAWTON C MURRAY K GARBRECHT F CASPER J
Citation: D. Margolis et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDHOOD AML - AN UPDATE OF THE MILWAUKEE EXPERIENCE, Blood, 90(10), 1997, pp. 4534-4534
HLA DISPARITY DETECTED BY AUTOMATED NUCLEOTIDE SEQUENCING MAY AID IN SELECTION OF ALTERNATIVE DONORS
Authors: BAXTERLOWE LA PARRISH R MARGOLIS D SZMANIA S SEURYNCK K WHITE J WANK T MOLTER M HAZLETT L DROBYSKI W GARBRECHT F PIETRYGA D HOROWITZ M CAMITTA B VESOLE D BURNS W FLOMENBERG N CASPER J KEEVERTAYLOR C
Citation: La. Baxterlowe et al., HLA DISPARITY DETECTED BY AUTOMATED NUCLEOTIDE SEQUENCING MAY AID IN SELECTION OF ALTERNATIVE DONORS, Blood, 90(10), 1997, pp. 478-478
A COMPARISON OF THE BALANCED AND UNBALANCED 1-19 TRANSLOCATION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PEDIATRIC-ONCOLOGY-GROUP(POG) STUDY
Authors: ABISH S CARROLL A SHUSTER J CAMITTA B PULLEN J
Citation: S. Abish et al., A COMPARISON OF THE BALANCED AND UNBALANCED 1-19 TRANSLOCATION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PEDIATRIC-ONCOLOGY-GROUP(POG) STUDY, Blood, 90(10), 1997, pp. 819-819
NEUROTOXICITY (NT) IN PATIENTS WITH STANDARD-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ON PEDIATRIC-ONCOLOGY-GROUP (POG)9405 - A PRELIMINARY-REPORT
Authors: BELL B ABISH S SHUSTER J CAMITTA B
Citation: B. Bell et al., NEUROTOXICITY (NT) IN PATIENTS WITH STANDARD-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) ON PEDIATRIC-ONCOLOGY-GROUP (POG)9405 - A PRELIMINARY-REPORT, Blood, 90(10), 1997, pp. 2490-2490
PROGNOSTIC-SIGNIFICANCE OF FLUORESCENCE INTENSITY OF SURFACE MARKER EXPRESSION IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BOROWITZ MJ SHUSTER J CARROLL AJ NASH M LOOK AT CAMITTA B MAHONEY D LAUER SJ PULLEN DJ
Citation: Mj. Borowitz et al., PROGNOSTIC-SIGNIFICANCE OF FLUORESCENCE INTENSITY OF SURFACE MARKER EXPRESSION IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 89(11), 1997, pp. 3960-3966
CHANGES IN RED-BLOOD-CELL METHOTREXATE PHARMACOLOGY AND THEIR IMPACT ON OUTCOME WHEN CYTARABINE IS INFUSED WITH METHOTREXATE IN THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDREN - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: GRAHAM ML SHUSTER JJ KAMEN BA LAND VJ BOROWITZ MJ CAMITTA B CHEO DL HARRISON MP LEVENTHAL BG PINKEL DP PULLEN DJ STEUBER P WHITEHEAD VM
Citation: Ml. Graham et al., CHANGES IN RED-BLOOD-CELL METHOTREXATE PHARMACOLOGY AND THEIR IMPACT ON OUTCOME WHEN CYTARABINE IS INFUSED WITH METHOTREXATE IN THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDREN - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Clinical cancer research, 2(2), 1996, pp. 331-337
THERAPY OF REFRACTORY OR RECURRENT CHILDHOOD ACUTE MYELOID-LEUKEMIA USING AMSACRINE AND ETOPOSIDE WITH OR WITHOUT AZACITIDINE - A PEDIATRIC-ONCOLOGY-GROUP RANDOMIZED PHASE-II STUDY
Authors: STEUBER CP KRISCHER J HOLBROOK T CAMITTA B LAND V SEXAUER C MAHONEY D WEINSTEIN H
Citation: Cp. Steuber et al., THERAPY OF REFRACTORY OR RECURRENT CHILDHOOD ACUTE MYELOID-LEUKEMIA USING AMSACRINE AND ETOPOSIDE WITH OR WITHOUT AZACITIDINE - A PEDIATRIC-ONCOLOGY-GROUP RANDOMIZED PHASE-II STUDY, Journal of clinical oncology, 14(5), 1996, pp. 1521-1525
HIGH-DOSE MELPHALAN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW RESCUE FOR RECURRENT PROGRESSIVE MALIGNANT BRAIN-TUMORS IN CHILDREN - A PILOT PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: MAHONEY DH STROTHER D CAMITTA B BOWEN T GHIM T PICK T WALL D YU L SHUSTER JJ FRIEDMAN H
Citation: Dh. Mahoney et al., HIGH-DOSE MELPHALAN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW RESCUE FOR RECURRENT PROGRESSIVE MALIGNANT BRAIN-TUMORS IN CHILDREN - A PILOT PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 14(2), 1996, pp. 382-388
UNIFORM APPROACH TO RISK CLASSIFICATION AND TREATMENT ASSIGNMENT FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SMITH M ARTHUR D CAMITTA B CARROLL AJ CRIST W GAYNON P GELBER R HEEREMA N KORN EL LINK M MURPHY S PUI CH PULLEN J REAMAN G SALLAN SE SATHER H SHUSTER J SIMON R TRIGG M TUBERGEN D UCKUN F UNGERLEIDER R
Citation: M. Smith et al., UNIFORM APPROACH TO RISK CLASSIFICATION AND TREATMENT ASSIGNMENT FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 14(1), 1996, pp. 18-24
AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS INTENSIVE CONSOLIDATIONCHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN CHILDHOOD
Authors: RAVINDRANATH Y YEAGER AM CHANG MN STEUBER CP KRISCHER J GRAHAMPOLE J CARROLL A INOUE S CAMITTA B WEINSTEIN HJ
Citation: Y. Ravindranath et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS INTENSIVE CONSOLIDATIONCHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN CHILDHOOD, The New England journal of medicine, 334(22), 1996, pp. 1428-1434
Risultati: 1-25 | 26-50 | 51-52